Earnings Review · 20 November 2026
The print
Results are in but not yet verified against a primary source in our ledger; this review updates the moment the audited figures land. What does not change is our read below.
How the market took it
On 2026-11-20 the shares closed at $82.90, -4.9% against the prior close of $87.17 (opening -4.5% from the prior close).
Did the flow confirm the move?
Underlying money flow reads as accumulation (21-day Chaikin Money Flow +0.33, five-day price change -5.1%, as of 2026-11-19, desk flow model).
Give the business its due
The business itself is genuinely strong: revenue growing about 6%,
net margins near 8%, a moderate competitive moat, backed by a 19%
return on equity.
Levels that matter
At $82.90 the shares sit 12% below the 52-week high of $94.60 and 55% above the low of $53.51 (72% of the way up the range). The 50-day average is $84.40, above the price. The 200-day average is $79.69, below the price.
The valuation lens
The shares trade close to our fair-value estimate (+8% margin of safety): fairly priced, little cushion for a miss. Fair value lands near $90 against a $82.90 share price, a margin of safety of about 8%. The trailing multiple sits around 26 times earnings, which only makes sense if the growth holds.
The
ethical lens, our differentiator
Screens compliant (both standards agree). A name values-conscious investors can weigh on the merits.
The verdict for a values-conscious investor
It clears the screen; size it to your own risk and conviction. One quarter, strong or soft, does not decide whether a holding is suitable.
This is analysis, not financial advice. Always manage your risk.